- $6.46bn
- $5.72bn
- $4.40bn
- 64
- 31
- 98
- 70
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K/A | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,616 | 2,365 | 3,208 | 4,095 | 4,404 |
Cost of Revenue | |||||
Gross Profit | 803 | 541 | 1,124 | 1,216 | 1,432 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6,318 | 4,173 | 4,224 | 5,690 | 4,879 |
Operating Profit | -2,702 | -1,808 | -1,016 | -1,595 | -476 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2,600 | -1,797 | -1,051 | -1,579 | -332 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2,602 | -1,753 | -1,062 | -1,585 | -340 |
Net Income Before Extraordinary Items | |||||
Net Income | -2,602 | -1,753 | -1,062 | -1,585 | -340 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2,602 | -1,753 | -1,062 | -1,585 | -340 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -11.4 | -5.4 | -2.88 | -4.18 | -0.755 |